vs

Side-by-side financial comparison of PRECISION BIOSCIENCES INC (DTIL) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.

SMARTFINANCIAL INC. is the larger business by last-quarter revenue ($53.8M vs $34.2M, roughly 1.6× PRECISION BIOSCIENCES INC). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs 25.4%, a 33.4% gap on every dollar of revenue. Over the past eight quarters, PRECISION BIOSCIENCES INC's revenue compounded faster (39.5% CAGR vs 15.4%).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.

DTIL vs SMBK — Head-to-Head

Bigger by revenue
SMBK
SMBK
1.6× larger
SMBK
$53.8M
$34.2M
DTIL
Higher net margin
DTIL
DTIL
33.4% more per $
DTIL
58.9%
25.4%
SMBK
Faster 2-yr revenue CAGR
DTIL
DTIL
Annualised
DTIL
39.5%
15.4%
SMBK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DTIL
DTIL
SMBK
SMBK
Revenue
$34.2M
$53.8M
Net Profit
$20.1M
$13.7M
Gross Margin
Operating Margin
36.6%
Net Margin
58.9%
25.4%
Revenue YoY
5261.1%
Net Profit YoY
213.5%
21.6%
EPS (diluted)
$2.62
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTIL
DTIL
SMBK
SMBK
Q1 26
$53.8M
Q4 25
$34.2M
$53.3M
Q3 25
$13.0K
$51.1M
Q2 25
$18.0K
$49.2M
Q1 25
$29.0K
$46.8M
Q4 24
$638.0K
$46.8M
Q3 24
$576.0K
$44.2M
Q2 24
$49.9M
$40.4M
Net Profit
DTIL
DTIL
SMBK
SMBK
Q1 26
$13.7M
Q4 25
$20.1M
$13.7M
Q3 25
$-21.8M
$13.7M
Q2 25
$-23.5M
$11.7M
Q1 25
$-20.6M
$11.3M
Q4 24
$9.6M
Q3 24
$-16.4M
$9.1M
Q2 24
$32.7M
$8.0M
Operating Margin
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
36.6%
31.3%
Q3 25
-158976.9%
33.2%
Q2 25
-121538.9%
29.0%
Q1 25
-76248.3%
29.0%
Q4 24
26.5%
Q3 24
-3693.6%
24.3%
Q2 24
48.4%
25.6%
Net Margin
DTIL
DTIL
SMBK
SMBK
Q1 26
25.4%
Q4 25
58.9%
25.7%
Q3 25
-167476.9%
26.8%
Q2 25
-130666.7%
23.8%
Q1 25
-70913.8%
24.0%
Q4 24
20.6%
Q3 24
-2851.6%
20.7%
Q2 24
65.6%
19.8%
EPS (diluted)
DTIL
DTIL
SMBK
SMBK
Q1 26
$0.81
Q4 25
$2.62
$0.81
Q3 25
$-1.84
$0.81
Q2 25
$-2.13
$0.69
Q1 25
$-2.21
$0.67
Q4 24
$0.57
Q3 24
$-2.25
$0.54
Q2 24
$4.67
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTIL
DTIL
SMBK
SMBK
Cash + ST InvestmentsLiquidity on hand
$115.6M
$346.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$92.2M
$562.2M
Total Assets
$154.4M
$5.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTIL
DTIL
SMBK
SMBK
Q1 26
$346.1M
Q4 25
$115.6M
$464.4M
Q3 25
$44.9M
$557.1M
Q2 25
$62.2M
$365.1M
Q1 25
$77.2M
$423.0M
Q4 24
$86.3M
$387.6M
Q3 24
$101.2M
$192.9M
Q2 24
$123.6M
$342.8M
Total Debt
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
Q3 25
$1.3M
Q2 25
$7.0M
Q1 25
$7.6M
Q4 24
$8.1M
Q3 24
$9.0M
Q2 24
$12.7M
Stockholders' Equity
DTIL
DTIL
SMBK
SMBK
Q1 26
$562.2M
Q4 25
$92.2M
$552.4M
Q3 25
$16.6M
$538.4M
Q2 25
$34.1M
$519.0M
Q1 25
$49.3M
$505.8M
Q4 24
$56.4M
$491.3M
Q3 24
$64.9M
$489.0M
Q2 24
$74.7M
$472.5M
Total Assets
DTIL
DTIL
SMBK
SMBK
Q1 26
$5.9B
Q4 25
$154.4M
$5.9B
Q3 25
$93.5M
$5.8B
Q2 25
$108.9M
$5.5B
Q1 25
$124.4M
$5.4B
Q4 24
$136.4M
$5.3B
Q3 24
$153.3M
$4.9B
Q2 24
$165.8M
$4.9B
Debt / Equity
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
Q3 25
0.00×
Q2 25
0.01×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.03×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTIL
DTIL
SMBK
SMBK
Operating Cash FlowLast quarter
$-11.3M
Free Cash FlowOCF − Capex
$-11.3M
FCF MarginFCF / Revenue
-32.9%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
$-11.3M
$61.7M
Q3 25
$-15.3M
$16.9M
Q2 25
$-20.3M
$14.0M
Q1 25
$-19.1M
$14.3M
Q4 24
$-58.4M
$52.7M
Q3 24
$-5.9M
$12.4M
Q2 24
$-14.9M
$16.5M
Free Cash Flow
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
$-11.3M
$59.3M
Q3 25
$16.6M
Q2 25
$-20.3M
$13.2M
Q1 25
$-19.1M
$13.4M
Q4 24
$-58.7M
$46.3M
Q3 24
$-6.0M
$11.3M
Q2 24
$-14.9M
$15.4M
FCF Margin
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
-32.9%
111.3%
Q3 25
32.4%
Q2 25
-112627.8%
26.9%
Q1 25
-65917.2%
28.5%
Q4 24
-9199.8%
98.9%
Q3 24
-1033.2%
25.7%
Q2 24
-29.9%
38.2%
Capex Intensity
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
0.1%
4.5%
Q3 25
0.0%
0.6%
Q2 25
11.1%
1.6%
Q1 25
220.7%
2.0%
Q4 24
39.2%
13.7%
Q3 24
6.8%
2.4%
Q2 24
0.1%
2.7%
Cash Conversion
DTIL
DTIL
SMBK
SMBK
Q1 26
Q4 25
-0.56×
4.50×
Q3 25
1.23×
Q2 25
1.20×
Q1 25
1.27×
Q4 24
5.47×
Q3 24
1.36×
Q2 24
-0.45×
2.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTIL
DTIL

Segment breakdown not available.

SMBK
SMBK

Net Interest Income$45.9M85%
Noninterest Income$7.9M15%

Related Comparisons